
Acorda Therapeutics ACOR
Quarterly report 2024-Q1
added 05-14-2024
Acorda Therapeutics Total Inventories 2011-2026 | ACOR
Annual Total Inventories Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.2 M | 12.8 M | 18.5 M | 28.7 M | 25.2 M | 29 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29 M | 12.8 M | 21.7 M |
Quarterly Total Inventories Acorda Therapeutics
| 2024-Q1 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.1 M | 13.5 M | 12.8 M | 15.3 M | 15.3 M | 14.8 M | 18.5 M | 20.6 M | 25.4 M | 27.4 M | 28.7 M | 28.7 M | 28.7 M | 28.7 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 29 M | 29 M | 29 M | 29 M | 37.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 37.5 M | 12.8 M | 23.8 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioCardia
BCDA
|
4 K | $ 1.36 | 5.04 % | $ 28.8 M | ||
|
BioXcel Therapeutics
BTAI
|
679 K | $ 1.63 | -2.37 % | $ 4.13 M | ||
|
AbCellera Biologics
ABCL
|
6.34 M | $ 3.65 | 0.97 % | $ 1.09 B | ||
|
Catalyst Biosciences
CBIO
|
4.28 M | $ 11.55 | -4.47 % | $ 760 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Codexis
CDXS
|
1.8 M | $ 1.08 | 6.93 % | $ 79.3 M | ||
|
Cerus Corporation
CERS
|
38.2 M | $ 2.64 | 2.93 % | $ 487 M | ||
|
Coherus BioSciences
CHRS
|
62.6 M | $ 1.66 | -0.9 % | $ 156 M |